Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP



Similar documents
Clinical Priorities for Alcohol and Drugs in Public Health

Sheffield Future Commissioning of Drug & Alcohol Community Treatment

drug treatment in england: the road to recovery

The story of drug treatment

Hepatitis C Infections in Oregon September 2014

Alcohol and drugs prevention, treatment and recovery: why invest?

Beginner's guide to Hepatitis C testing and immunisation against hepatitis A+B in general practice

Trends in Drug Treatment

Lincolnshire Alcohol and Drug Strategy

Why invest? How drug treatment and recovery services work for individuals, communities and society

REVIEW OF DRUG TREATMENT AND REHABILITATION SERVICES: SUMMARY AND ACTIONS

Adult drug treatment plan 2009/10. Part 1: Strategic summary, needs assessment and key priorities

THE STORY OF DRUG TREATMENT

POWDER COCAINE: HOW THE TREATMENT SYSTEM IS RESPONDING TO A GROWING PROBLEM

Alcohol data: JSNA support pack

BACKGROUND MEDIA INFORMATION Fast facts about liver disease

Impact of drugs and alcohol on individuals and the community

About Public Health England

Addressing Alcohol and Drugs in the Community. Cabinet member: Cllr Keith Humphries - Public Health and Protection Services

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT ALCOHOL MISUSE

Protecting and improving the nation s health. Drug treatment in England

Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center

Substance Misuse. See the Data Factsheets for more data and analysis:

Joint Commissioning Panel for Mental Health

REVISED SUBSTANCE ABUSE GRANTMAKING STRATEGY. The New York Community Trust April 2003

WHO/UNODC/UNAIDS position paper Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention

Liver means Life. Why this manifesto? We are eager to ensure. that we can contribute. to society as much. as possible, and we. are equally keen to

7.11 Substance misuse

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY TENTH WAVE WORK PROGRAMME DRUG MISUSE. Psychosocial interventions in drug misuse

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.

Milton Keynes Drug and Alcohol Strategy

Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During

Treatment of Alcoholism

Testimony of The New York City Department of Health and Mental Hygiene. before the

The Recovery Pathway Service forms a key component of the Sunderland Integrated Substance Misuse Service, as illustrated below:

Adult drug treatment plan 2007/08 Part 1 Section A: Strategic summary Section B: National targets Section C: Partnership performance expectations

Resources for the Prevention and Treatment of Substance Use Disorders

HOSC Report Integrated community drugs and alcohol service retendering options beyond April 2016

practitioners and physician assistants.advanceweb.com/features/articles/alcohol Abuse.aspx

Topic Area - Dual Diagnosis

Community Drug / Alcohol Pathways. Rachael Sadegh DAAT Co-ordinator

SERVICE SPECIFICATION FOR THE PROVISION OF DELIVERY OF SERVICES FOR DRUG AND ALCOHOL TREATMENT AND RECOVERY. (Schedule 1 of the Agreement)

Principles for commissioning a substance misuse treatment system

Heroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director

The NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System.

NHS Swindon and Swindon Borough Council. Executive Summary: Adult Alcohol Needs Assessment

Treatment Approaches for Drug Addiction

HIGH SUCCESS RATE OF BUTTERY REHABILITATION PROGRAMS

Reducing Drug Use, Reducing Reoffending Are programmes for problem drug-using offenders in the UK supported by the evidence?

FALLING DRUG USE: THE IMPACT OF TREATMENT

Treatments for drug misuse

Public Health England. Alcohol & alcohol related harm

Drug misuse and dependence: UK guidelines on clinical management

TREATMENT MODALITIES. May, 2013

Treatment Approaches for Drug Addiction

Hepatitis C. David Mutimer Queen Elizabeth Hospital Liver Unit Birmingham. Substance Misuse Treatment in the West Midlands. How can we reduce harm?

Care Management Council submission date: August Contact Information

Improving smoking cessation in drug and alcohol treatment

Substance misuse among young people in England

THE BASICS. Community Based Medically Assisted Alcohol Withdrawal. World Health Organisation The Issues 5/18/2011. RCGP Conference May 2011

OVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use

Testimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment

GUIDELINES FOR COMMUNITY ALCOHOL DETOXIFICATION IN SHARED CARE

Getting help for a drug problem A guide to treatment

Alcohol treatment in England

Dual Diagnosis. Dual Diagnosis Good Practice Guidance, Dept of Health (2002);

Wairarapa Wellness. A brief overview of mental health and addiction services in Wairarapa.

An independent review into the impact on employment outcomes of drug or alcohol addiction, and obesity. Call for evidence

Alcohol-use disorders: alcohol dependence. Costing report. Implementing NICE guidance

2. Local Data to reduce Alcohol Related Harm and Comparison Groups

World Health Organization

Case Finding for Hepatitis B and Hepatitis C

Transcription:

Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP

Habit is habit, and not to be flung out of the window by any man, but coaxed down-stairs one step at a time. Samuel Langhorne Clemens

Trends and Issues Traditional drugs Alcohol Addiction to Medicines Novel Psychoactives Third sector Involvement Prevalence Age Co-morbidities Recovery v Harm Reduction

Trends in illicit drug use in the last year among adults, by age group, 1996 to 2013 to 2014, Crime Survey for England and Wales

Estimates suggest over 300,000 problematic heroin & crack users in the UK Over 6 billion s a year spent on illicit drugs in the UK 70% of acquisitive crime drug related Over a 20 year injecting career, 75% will become infected with hepatitis C Mortality rates between 6-16x higher than general population

Ageing Populations

Age Effects? Trends in the proportion of reported drug-induced deaths in the 40-59 age group, in selected EU Member States

Co-morbiditity COPD Ischaemic Heart Disease Hypertension and CKD Liver Disease including Cirrhosis Diabetes Mental Health Poly Drug Use

Role of Primary Care Chronic relapsing nature of condition patient stays registered whether still using, on OST or abstinent Advantages of primary care treatment, including continuity and the treatment of associated health problems Familiarity in dealing with complex problems needing behavioural change

What is Recovery? Recovery is an individual, person-centred journey as opposed to an end state and will mean different things to different people (Drug Strategy 2010) Medical Assisted Recovery and Abstinence both count! An informed choice by an individual Support structures in place Detoxification needs to take place between preparation and after care. It should never be undertaken as a stand-alone procedure

Recovery as a journey Recovery Reducing Harm engagement Supported Stability Reintegration Abstinence

What else is needed? Psychosocial Interventions access- preferably in house Specialist Support around Complex Issues Access to Medically Assisted Withdrawal and Rehabilitation Links to Mutual Aid Prescribing to support Abstinence

Alcohol in the mix Public Health advises just one glass of wine a day

The numbers PHE data ENGLAND LAs PRACTICE GP Total Population 53,588,218 352,554 6,487 1,606 Adult Population 43,580,873 286,716 5,275 1,306 Dependent drinkers 1,568,911 10,322 190 47 Increasing and Higher Risk 9,849,277 64,798 1,192 295 Alcohol interventions in Primary Care 14 FACTS FIGURES LAs 152 Inc + High % 22 Dep % 3.8 Practices 8,261 GPs 33,364 13 Alcohol interventions in Primary Care

Chronic Liver Disease Key drivers for growth in burden and mortality, First 3 all preventable: Alcohol Chronic viral hepatitis B/C Obesity Non-alcoholic fatty liver disease (NAFLD) leading to non-alcoholic steatohepatitis (NASH) Others including autoimmune or inherited eg Primary Biliary Cirrhosis (PBC), haemochromatosis

English Data Figure 15: Estimated number of people living with HCV-related cirrhosis or decompensated cirrhosis/hcc in England: 1995-2020 (95% credible intervals are given in parentheses) Hepatitis C in the UK 2013 Report, Public Health England

Prevalence of HCV Infection Overall, it is estimated that around 214,000 people (0.4%) in the UK are chronically infected with hepatitis C. Despite being a curable infection only 3% of those infected receive treatment each year. Hepatitis C in the UK 2013. PHE publications gateway number: 2014058 July 2014

Treatment rates in England by SHA Percentage of prevalent population Proportion of estimated prevalent population treated for hepatitis C No SHA area manages to treat more than 3% of their infected population in a year An audit of Strategic Health Authority hepatitis C governance 2009 Hepatitis C Trust

Why Treat Hepatitis C? Van de Meer et al JAMA 2012

Referral for treatment One report estimated that there are more than 13,000 new cases of hepatitis C infection in the UK per year yet we are only treating around 5,000 per year It has been estimated that <1% of IDUs are being treated. In the dark. An audit of hospital hepatitis C services across England. London: The All Party Parliamentary Hepatology Group, August 2010.

Primary Care has a key role to play Prevent transmission Increase detection Diagnose infection in people who have the disease Arrange treatment in those with chronic infection with the aim of eradicating the virus, or at least minimising its effects HBV is preventable with an effective vaccine With modern therapy, depending on the genotype of HCV between 60-85% of patients with chronic HCV can be cured Treatment for HCV has been recommended by NICE

Addiction to Medicines

Opioid Analgesics

1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 Opioid deaths mirror prescribing* 250 200 150 100 50 0 Other opiate Tramadol Dihydrocodeine not from compound may signal an emerging problem in the UK similar to the issue that is now well established in the USA. ONS Deaths Related to Drug Poisoning in England and Wales, 2013 and Prescription opioid abuse in the UK, Giraudon I et al., British Journal of Clinical Pharmacology 2013 Addiction to medicines policy November 2014 * Not including illicit opioids

Newer Drugs Novel Psychoactive Substances, Club Drugs, Legal Highs

A Growing Problem

Drug harms in the UK: a multicriteria decision analysis The Lancet, Volume 376, Issue 9752, Pages 1558-1565, 6 November 2010 doi:10.1016/s0140-6736(10)61462-6 Drugs ordered by their overall harm scores, showing the separate contributions to the overall scores of harms to users and harm to others. The weights after normalisation (0 100) are shown in the key (cumulative in the sense of the sum of all the normalised weights for all the criteria to users, 46; and for all the criteria to others, 54). CW=cumulative weight. GHB=γ hydroxybutyric acid. LSD=lysergic acid diethylamide.

Public Health v Primary Care Oh, East is East, and West is West, and never the twain shall meet Rudyard Kipling

Commissioning Role of health and Well Being Board Other partners Third Sector, Police & Crime Commissioners, Social Services, Housing etc. Links to Secondary Care Services Pathways

Funding Issues CCG / Public Health split in some areas Competing Priorities Drug and Alcohol treatment not part core service for GPs However required to work with patients Huge impact on hospital admissions

Key Points Long term drug use leads to multiple physical and mental health problems and premature ageing Patterns of drug use change but remain worryingly high Poly drug use is the usual pattern Primary Care with support from Secondary Care and the Third Sector can provide effective care and aftercare